Dr. Berman talks about his research in fat stem cells.
Most people (doctors included) believe that stem cell therapy is still several years away from being available to the public. However, since 2010, in association with my partner, urologist Elliot Lander, MD, FACS, we have been conducting stem cell deployment as part of an ongoing investigative project collecting data on thousands of treated patients. After several successful outcomes in the orthopedic arena that I obtained in collaboration with orthopedic surgeon, Dr. Tom Grogan, Elliot and I formed the California Stem Cell Treatment Center followed a year later by the Cell Surgical Network the worlds largest network of stem cell physicians utilizing technology we developed with renown Korean plastic surgeon, Dr. Lee Hee Young. We currently teach doctors from the USA and worldwide our techniques using the CSN Time Machine to effectively harvest and process fat into stromal vascular fraction (SVF) rich in stem cells. Starting with a 10 minute mini-liposuction painlessly done under local anesthesia, this 1 hour process has yielded results that have been successfully recapitulated all over the world. Currently, there are about 100 CSN centers in the US and many more throughout the world, including dozens in China in association with our partners, RE Stem Biotech.
We are now in a new era of medicine. Our bodies are made up of dozens of trillions of cells. Up until now, medicine was predominantly aimed at keeping our cells healthy and alive through diet, exercise, medications to eradicate disease, or supplements to help our cells stay healthy, but now, going forward, we have the opportunity to replace injured or dying cells with our own DNA coded stem cells. These cells can not cause an allergic response or be rejected. While many people consider this experimental, we really consider it investigational but not really experimental. This may be a NEW era in medicine, but it really reflects perhaps the OLDEST form of intervention. Before we had any kind of medical intervention we had to rely on our bodys natural cell defense to keep us healthy. We now have the ability to unlock and harvest huge quantities of these repair cells for immediate use and, further, we can send samples to our lab where they can be cryopreserved and expanded as millions of stem cells for later use. Indeed, we have coined the term CRT Cell Renewal Therapy to describe how we foresee the future of medicine whereby your natural spare parts in the form of your own DNA cultivated stem cells will be made available to keep your body healthy and extend longevity for years beyond anything ever imaginable.
Stem cells are basically unspecialized cells that can replicate and differentiate (i.e. turn into other specialized cells). They tend to have three basic properties: 1) anti-inflammatory; 2) immune-modulatory and 3) reparative or regenerative. Most people think an embryo is the most common source for stem cells. While most stem cell studies started by using embryos, there are a number of issues and problems associated with their use. Not only are there ethical concerns, embryonic stem cells can sometimes form tumors (i.e. teratomas).
There are also a lot of stem cells naturally found in our body. Most people are aware of bone marrow derived stem cells. In recent years, bone marrow has been a source for stem cells particularly for orthopedic conditions. However, stem cell yields in bone marrow tend to be between 50,000 and 200,000 with some of the newer technology. Adipose (fat) tissue also houses vast quantities of stem cells. In fact, just 30 ccs (2 tablespoons) of fat can yield between 10 and 30 million stem cells.
Our fat derived stem cells have a tremendous capacity to turn into a large variety of tissues. Originally, because of their mesenchymal origin we thought they could only turn into fat, cartilage, bone, muscle, connective tissue, blood vessels and nerve tissue, but now we have studies showing theyve turned into practically every kind of cell in the body. While the bone marrow proponents will sing the virtues of bone marrow stem cells for cartilage repair, it turns out that fat derived cells are an even greater source for cartilage repair and production. Compared to a bone marrow harvest, its so simple to harvest a little fat and the yields are generally very high making fat an ideal source for stem cells.
When we started our studies in 2010 the critics suggested it might not be safe. Our initial study made SAFETY the primary objective and the clinical outcomes a secondary objective. Our safety study of over 1500 patients has shown that there are no significant adverse events related to the deployment of SVF. Indeed, the only real issues have been some mild discomfort around the liposuction site something we naturally expect. Weve submitted this paper for publication.
While there are a growing number of doctors claiming to provide stem cell treatments, we believe the most ethical approach is to do it under the umbrella of IRB approved research protocols. An IRB is an Institutional Review Board or an organization of members responsible for approving and overseeing research on humans. IRBs are approved under the auspices of the U.S. Department of Human Research Protection. As such, our patients understand the investigational nature of our activities, are provided appropriate informed consents, and are followed continuously on an online database to chart their progress or any issues of concern. This will allow us to not only accumulate safety data but demonstrate effectiveness of treatments and help us to improve treatment programs going forward.
We already have a number of very innovative treatments in progress. For example, one of our approved studies involves deployment of cells via an Ommaya reservoir. This is a device that connects a port under the scalp via a tube directly into the ventricle of the brain where cells can be added to the cerebral spinal fluid. This concept evolved by working with renown Brain Surgeon, Christopher Duma, MD, FACS. It was preceded by safety studies on laboratory rats and 30 patients later is showing some significant progress.
As you can imagine, with new technologies, patients often come to you when theyve exhausted most other traditional treatments. Weve now had a lot of experience to understand how well cell therapy can work even though were continuing to gather data and look for ways of optimizing treatments. So, for example, most patients with arthritic knees will consider stem cell deployment after theyve tried pain medication, steroids, hyaluronan injections and even arthroscopy. None of these are actually treatments that repair the problem but rather mask the pain or temporize the situation. If theres cartilage in the knee then it can potentially signal your stem cells to repair the joint. We now understand that acute injuries probably respond better than chronic ones because there are more messages (cytokines) directing and instructing the stem cells into action and repair. Still, until we have enough data and publish enough articles to support these positions our concepts remain conjecture awaiting to be proven.
Patients are also concerned about whether these procedures are FDA approved. Technically, the FDA only approves drugs and devices. Were actually performing a surgical procedure and the FDA does not approve surgery. However, we are working with the FDA to have our system evaluated for potential FDA approval. Our initial FDA studies will be aimed at knee arthritis with the goal to show autologous SVF is more effective than a placebo. This will be done with a double blind controlled study. I doubt we will do FDA studies for every potential condition rather, doctors will ultimately gather data and/or do their own research and accumulate results to support the positive use of SVF for a large host of inflammatory and degenerative conditions.
Since starting our investigative network in 2012, weve not only gone to the animal lab for the Ommaya reservoir program, weve expanded our research into areas of cancer, paralysis, and most recently, concussion. My son, Sean, in fact, has been doing some terrific animal research in the area of concussion where hes been able to first, induce reproducible concussions in trained animals and show that they generally take two weeks to get better and re-learn their memory and motor skills; and second, by giving SVF via a tail vein injection after concussion, the rats get better so quickly that they regain their memory and motor skills right away. The implications for athletes, football especially, and the military are extraordinary.
There is a lot more information about our program that can be found at our website stemcellrevolution.com. Still, while this currently remains an area of investigation, it also represents one of the most exciting transitions in the field of medicine with tremendous potential now and in the future.
Read the latest news articles about Dr. Berman's Stem Cell work: Latest Stem Cell News about Dr. Berman
See the rest here:
Dr. Bermans's Stem Cell Therapy - Mark Berman MD
- News Royal Oak native meets woman she saved with vital stem cell donation Jenn Schanz 11 - WXYZ - February 18th, 2020
- UCLA researchers discover new compound that promotes lung health - Newswise - February 18th, 2020
- Readers and Writers: A nonfiction sampler on the mind/body/spirit continuum - St. Paul Pioneer Press - February 15th, 2020
- Breakthrough in Stem Cell Research: First Image of Niche Environment | Newsroom - UC Merced University News - February 14th, 2020
- Scientists Think They Know How Stress Causes Gray Hair - Thrive Global - February 14th, 2020
- University of Delaware researcher receives $250K grant for new biotherapies - Technical.ly Brooklyn - February 14th, 2020
- Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant? - Cancer Network - February 14th, 2020
- Health care professionals offer insight to stem cell injection claims - WOWT - February 12th, 2020
- New Report Counters Claims on the Origin of Gastric Cancer - The Scientist - February 12th, 2020
- AlloVir Receives the European Medicines Agency PRIME Designation for Viralym-M, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy -... - February 12th, 2020
- BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn Regulatory Pathway for Approval in ALS - GlobeNewswire - February 12th, 2020
- Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update - BioSpace - February 11th, 2020
- Cancer patients use more blood than those fighting any other disease - Portsmouth Daily Times - February 11th, 2020
- Sinai and Synapses names new class of 15 fellows - Covalence - February 11th, 2020
- Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV (enfortumab vedotin-ejfv) in Combination with Immune Therapy... - February 11th, 2020
- Stem Cell Alopecia Treatment Market 2020 | Research, Opportunities, Emerging Trends, Competitive Strategies and Forecasts 2020-2026 - Instant Tech... - February 7th, 2020
- Parkinson's Traced to Malfunctioning Brain Cells at Birth - Newsmax - February 7th, 2020
- Will Dialysis Become a Thing of the Past? - Jewish Link of Bronx, Westchester and Connecticut - February 7th, 2020
- In small study, hints of promise for 'natural killer' cell therapy - BioPharma Dive - February 6th, 2020
- Maybe Memorizing the Krebs Cycle Was Worthwhile After All - Medscape - February 6th, 2020
- Global Personalized Medicine Market Analysis (2016 to 2026) - Total Market Value is Expected to Reach $3.92 Trillion by 2026 - ResearchAndMarkets.com... - February 6th, 2020
- Hyperbaric oxygen therapy can improve cardiac function in healthy, aging - The Jerusalem Post - February 6th, 2020
- Will Dialysis Become a Thing of the Past? - Jewish Link of New Jersey - February 6th, 2020
- "Mini Brains" Are Not like the Real Thing - Scientific American - January 31st, 2020
- Consumer Claims Over Peter Thomas Roth's Alleged "False Advertising" of Skincare Products to Go to Jury - The Fashion Law - January 31st, 2020
- NIH Grants $4.8 Million to Gladstone Institutes to Study ApoE4 in Alzheimer's - PharmaLive - January 31st, 2020
- Judith C. Brings WELCOME TO THE CANCER CAFE to The Marsh Berkeley - Broadway World - January 31st, 2020
- The Center for Breakthrough Medicines is Building the World's Largest Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO)... - January 22nd, 2020
- Toxys Strengthens Leadership Team with Appointment of CBO and COO Positions - BioSpace - January 22nd, 2020
- Share the Love on Valentine's Day! Join the Cure 4 The Kids Foundation Blood Drive and Registry Event - Nevada Business Magazine - January 22nd, 2020
- Botox, medical drips and more offered at NVY Center - SILive.com - January 18th, 2020
- Walter named Edward P. Evans Endowed Professor - Washington University School of Medicine in St. Louis - January 18th, 2020
- Who are the 10 Most Innovative Biopharma Companies? - BioSpace - January 18th, 2020
- Using RNA as a Delivery Vehicle Is the Magic Bullet to Cure Gene Mutation - Science Times - January 13th, 2020
- The F.D.A. Is in Trouble. Heres How to Fix It. - The New York Times - January 12th, 2020
- Stem Cell and Regenerative Medicine Action Awards to be Presented at World Stem Cell Summit on January 23 at the Hyatt Regency Miami - Yahoo Finance - January 10th, 2020
- John Theurer Cancer Center Announces Appointment of Five New Physicians - Newswise - January 10th, 2020
- Orgenesis Announces Addition of University of California, Davis, to its Point of Care Network; UC Davis Health to Utilize Orgenesis Point of Care... - January 10th, 2020
- Aspen Neuroscience Announces Board of Directors and Scientific Advisory Board - PRNewswire - January 10th, 2020
- How Kyoto Is Rebuilding Itself As A Nanotech And Regenerative Medicine Powerhouse - Forbes - January 10th, 2020
- ASH 2019 | The impact of donor clonal hematopoiesis on aGvHD and patient outcomes - AML Global Portal - January 9th, 2020
- New protocol could signal shift in bone regenerative medicine - PR Web - January 7th, 2020
- Stem Cell Alopecia Treatment Market 2020 Size, Share Metrics, Growth Trends and Forecast to 2026 - Pro News Time - January 7th, 2020
- Firm adds a new wrinkle to anti-aging products - The Logan Banner - January 1st, 2020
- The Major Discoveries That Could Transform the World in the Next Decade - Livescience.com - January 1st, 2020
- Alligator Skin, Human Clones and Other Things Being Banned in 2020 - The New York Times - December 31st, 2019
- ESPN reporter Edward Aschoff diagnosed with pneumonia and HLH before he died - WPVI-TV - December 31st, 2019
- ESPN reporter Edward Aschoff was diagnosed with pneumonia and HLH before he died. What is HLH? - Q13 News Seattle - December 29th, 2019
- The top 45 stories of the decade - ISRAEL21c - December 29th, 2019
- ESPN reporter diagnosed with pneumonia, HLH. What is HLH? - KXLY Spokane - December 27th, 2019
- Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy fo | DDDT - Dove Medical Press - December 19th, 2019
- Stem Cell Therapy is a Must Try Method for Permanent Relief from Pain, Says Integrated Medical Center of Corona - Press Release - Digital Journal - December 19th, 2019
- Hackensack Meridian Health and Georgetown Lombardi Comprehensive Cancer Center Become Associate Members of the New York Genome Center - BioSpace - December 19th, 2019
- Orthopaedic Surgeon, Dr. Jeffrey Carlson, first in Central and Eastern Virginia to implant the M6-C Artificial Cervical Disc - OrthoSpineNews - December 19th, 2019
- Experts and Attitude Help Grandfather Face Primary Central Nervous System Lymphoma - Dana-Farber Cancer Institute - December 19th, 2019
- 100 hospitals and health systems with great neurosurgery and spine programs | 2019 - Becker's Hospital Review - December 14th, 2019
- Therapeutic Exosomes Go From Vein to Brain - Technology Networks - December 13th, 2019
- Blinatumomab May Become New Standard of Care for Post-Reinduction Therapy in Young Patients With B-ALL - Cancer Therapy Advisor - December 13th, 2019
- Deacon Butch King learns to accept the 'gift' of cancer - Arkansas Catholic - December 13th, 2019
- How cancer cells grow and spread in colon tissue? - Tech Explorist - December 5th, 2019
- Hidden Dangers Of Dating Apps: Sex Offenders, Including Rapists, Are Using Them. Why Do Companies Allow It? - Kaiser Health News - December 5th, 2019
- Cellex Opens New Plant to Manufacture Innovative Cell Therapy Products for Cancer - PRNewswire - December 5th, 2019
- Analysis Shows Need for Better Classification of Rare Lymphoma - Patch.com - December 5th, 2019
- Aledo and Ennis will be a legendary regional final matchup, and not because of what's on the playing field - The Dallas Morning News - December 5th, 2019
- Volumetric Bioprinting: The New Paradigm in Regenerative Medicine - Advanced Science News - December 2nd, 2019
- Heres what you might have missed from the week in business - The Boston Globe - December 2nd, 2019
- Genome Editing Services, World Markets to 2030: Focus on CRISPR - The Most Popular Genome Manipulation Technology Tool - PRNewswire - November 29th, 2019
- The FutureAnd the End?of AIDS - Columbia University Irving Medical Center - November 29th, 2019
- Visiongain Report Looks at Opportunities within the $1.8bn Acute Myeloid Leukaemia Market - P&T Community - November 29th, 2019
- ENCORE: Why There Are So Few Black Men In Medicine; Family of Stem Cell Donor Connects With Recipient 20 Years Later; Forecasting Volcanic Eruptions -... - November 26th, 2019
- Trial cancer treatment in Wichita - KAKE - November 26th, 2019
- Personalized Stem Cells, Inc. Sponsors Arthritis Foundation Event in Los Angeles - PR Web - November 26th, 2019
- BioLineRx to Host Investor and Analyst Breakfast Meeting on December 5, 2019 in New York - P&T Community - November 26th, 2019
- AVITA Medical and the Gates Center for Regenerative Medicine at the University of Colorado Anschutz Medical Campus Enter into Collaboration to Explore... - November 26th, 2019
- Fred Hutch at ASH: Latest CAR T data BCMA, CD19, CD20 plus new insights on transplantation, gene therapy and more - Newswise - November 22nd, 2019
- ALS Stem Cell Therapy Developer Seeks Amendment to its AstroRx Trial - ALS News Today - November 22nd, 2019
- Stem Cell Alopecia Treatment Market: moving from experimentation to transformation in 2024 - WindStreetz - November 22nd, 2019
- For veterans, theres no better cause to push than helping other vets - Snoqualmie Valley Record - November 18th, 2019
- What to Know in Washington: Trump Ally in Impeachment Spotlight - Bloomberg Government - November 18th, 2019
- Possible Treatment Found for Contractures in CP, Childhood Paralysis, Early Study Shows - Cerebral Palsy News Today - November 14th, 2019